Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas bought 62,500 shares of the company’s stock in a transaction that occurred on Wednesday, January 15th. The shares were bought at an average cost of $0.80 per share, for a total transaction of $50,000.00. Following the transaction, the chief executive officer now directly owns 4,087,727 shares of the company’s stock, valued at $3,270,181.60. This trade represents a 1.55 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Grigorios Siokas also recently made the following trade(s):
- On Monday, January 13th, Grigorios Siokas purchased 163,666 shares of Cosmos Health stock. The stock was bought at an average price of $0.61 per share, for a total transaction of $99,836.26.
- On Friday, December 20th, Grigorios Siokas acquired 257,334 shares of Cosmos Health stock. The shares were bought at an average price of $0.58 per share, for a total transaction of $149,253.72.
Cosmos Health Stock Performance
Shares of NASDAQ COSM traded up $0.03 during mid-day trading on Thursday, hitting $0.83. The company had a trading volume of 594,649 shares, compared to its average volume of 358,919. Cosmos Health Inc. has a 12 month low of $0.47 and a 12 month high of $1.58. The firm has a market cap of $19.31 million, a P/E ratio of -0.34 and a beta of 5.57. The business’s 50-day simple moving average is $0.71 and its 200-day simple moving average is $0.91. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.44 and a quick ratio of 1.24.
Cosmos Health Company Profile
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Further Reading
- Five stocks we like better than Cosmos Health
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- How to Calculate Options Profits
- Micron Technology: Riding the AI Wave to Long-Term Growth
- What is the FTSE 100 index?
- 3 Cheap Small-Cap Banks for Dividend Growth Investors
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.